Lyell Immunopharma Statistics
NASDAQ: LYELHealth CareBiotechnology: Pharmaceutical PreparationsUSD
8.40-0.165 (-1.93%)
Market open · Delayed 15 min · as of Oct 8, 10:44 AM ET
Lyell Immunopharma by the numbers
Lyell Immunopharma has a market capitalization of $205.7 million based on 24.51M shares outstanding. With trailing EPS of $-12.86, Lyell Immunopharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 33.8% below its 50-day average and 54.9% below its 200-day average.
Average daily trading volume is 144.81K shares, or about $1.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LYEL valuation vs. peer median
| Metric | LYEL | Peer median | Difference |
|---|---|---|---|
| Market cap | $205.72M | $218.06M | -6% |
| Avg. volume | 144.81K | 177.81K | -19% |
Peer median across 8 companies: TRDA, SION, RNAC, GLSI, KROS, NATR, SLGL, MGNX.
Valuation
- Market cap
- $205.72M
- EPS (TTM)
- $-12.86
- Shares outstanding
- 24.51M
Price and trading
- Previous close
- 8.56
- Open
- 8.52
- Day range
- 8.21 – 8.52
- 52-week range
- 8.21 – 45.00
- 52-week change
- -51.61%
- Beta
- —
- Volume
- 21.84K
- Average volume
- 144.81K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 6, 2026
Additional statistics
- Market Cap
- 205.72M
- Forward Pe
- -1.33
- Eps
- -12.86
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 45.00
- Week52 Low
- 8.21
- Avg Volume
- 144.81K
- Shares Outstanding
- 24.51M
- Ma50
- 12.68
- Ma200
- 18.62
- Earnings Date
- Nov 6, 2026
- Pct From52w High
- -81.34%
- Pct From52w Low
- 2.25%